Abivax SA (AAVXF)
15.15
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Abivax Total Assets (Quarterly): 361.53M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 361.53M |
| June 30, 2023 | 185.92M |
| June 30, 2023 | 185.92M |
| December 31, 2022 | 81.01M |
| June 30, 2022 | 74.84M |
| June 30, 2022 | 74.84M |
| December 31, 2021 | 123.67M |
| June 30, 2021 | 65.56M |
| June 30, 2021 | 65.56M |
| December 31, 2020 | 87.69M |
| June 30, 2020 | 56.02M |
| June 30, 2020 | 56.02M |
| December 31, 2019 | 57.94M |
| June 30, 2019 | 62.08M |
| Date | Value |
|---|---|
| June 30, 2019 | 62.08M |
| December 31, 2018 | 61.83M |
| June 30, 2018 | 53.24M |
| June 30, 2018 | 53.24M |
| December 31, 2017 | 64.56M |
| June 30, 2017 | 63.13M |
| June 30, 2017 | 63.13M |
| December 31, 2016 | 64.06M |
| June 30, 2016 | 74.16M |
| June 30, 2016 | 74.16M |
| December 31, 2015 | 83.38M |
| June 30, 2015 | 100.22M |
| June 30, 2015 | 100.22M |
| December 31, 2014 | 46.17M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
56.02M
Minimum
Jun 2020
361.53M
Maximum
Dec 2023
106.71M
Average
74.84M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 145.90M |
| Cellectis SA | 334.27M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 192.20M |
| Innate Pharma SA | 203.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 144.86M |
| Shareholders Equity (Quarterly) | 216.67M |